Material Agreements

FG Imperii Acquisition Corp. entered into Administrative Services Agreement with FG Imperii Investors LLC valued at Administrative services agreement with sponsor (effective 2026-01-15).

“· An Administrative Services Agreement, dated January 15, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto”

FG Imperii Acquisition Corp. entered into Letter Agreement with Company, officers, directors, and Sponsor valued at Letter agreement among company, officers, directors, and sponsor (effective 2026-01-15).

“· A Letter Agreement, dated January 15, 2026, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto”

FG Imperii Acquisition Corp. entered into Registration Rights Agreement with Certain security holders valued at Registration rights agreement (effective 2026-01-15).

“· A Registration Rights Agreement, dated January 15, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto”

FG Imperii Acquisition Corp. entered into Investment Management Trust Agreement with Odyssey Transfer and Trust Company valued at Investment management trust agreement with trustee (effective 2026-01-15).

“· An Investment Management Trust Agreement, dated January 15, 2026, by and between the Company and Odyssey Transfer and Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto”

FG Imperii Acquisition Corp. entered into Private Warrant Agreement with Odyssey Transfer and Trust Company valued at Private warrant agreement (effective 2026-01-15).

“· Private Warrant Agreement, dated January 15, 2026, by and between the Company and Odyssey Transfer and Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.2 hereto”

FG Imperii Acquisition Corp. entered into Public Warrant Agreement with Odyssey Transfer and Trust Company valued at Public warrant agreement for warrants exercisable at $11.50 per share (effective 2026-01-15).

“· Public Warrant Agreement, dated January 15, 2026, by and between the Company and Odyssey Transfer and Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto”

Axogen, Inc. entered into Underwriting Agreement with Wells Fargo Securities, LLC and Mizuho Securities USA LLC, as representatives of the underwriters valued at 4,000,000 shares of its common stock, $0.01 par value per share, at a public offering price of $31.0 (effective 2026-01-21).

“On January 21, 2026, Axogen, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Wells Fargo Securities, LLC and Mizuho Securities USA LLC, as representatives of the underwriters (the “Underwriters”).”

QHSLab, Inc. terminated Repurchase Agreement with MedScience Research Group, Inc..

“QHSLab, Inc. (the “Company”) consummated a Note Repurchase Agreement (the “Repurchase Agreement”) with MedScience Research Group, Inc., a Florida corporation (“MedScience”).”

ProPhase Labs, Inc. entered into Stock Purchase Agreement with Generating Alpha Ltd. valued at ten million dollars ($10,000,000) (effective 2026-01-16).

“On January 16, 2026, ProPhase Labs, Inc. (“the Company”) entered into a Stock Purchase Agreement (“the Agreement”) with Generating Alpha Ltd. (“the Investor”), pursuant to which the Investor committed to provide the Company with up to ten million dollars ($10,000,000) of equity capital over time, at the Company’s election and subject to the terms and conditions set forth in the Agreement.”

BLOOMIA HOLDINGS, INC. amended First Amendment to Bridge Loan Agreement with Botman Bloembollen B.V., Mr. W.J. Jansen, Mr. H.J. Strengers (effective 2026-01-19).

“On January 19, 2026, the Borrowers entered into that certain First Amendment to Bridge Loan Agreement ("Bridge Loan Amendment")”

BIOCRYST PHARMACEUTICALS INC entered into Loan Agreement with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C., as Blackstone representatives, the lenders party thereto, and Wilmington Trust, National Association, as agent valued at $400 million (effective 2026-01-23).

“On January 23, 2026 (the “ Closing Date ”), BioCryst Pharmaceuticals, Inc., a Delaware corporation (“ BioCryst ”), entered into a Loan Agreement (the “ Loan Agreement ”), by and among BioCryst, as borrower, the guarantors from time to time party thereto, Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C., as the Blackstone representatives thereunder, the lenders from time to time party thereto and Wilmington Trust, National Association, as agent. The Loan Agreement provides for initial term loans in the principal amount of $400 million (the “ Term Loans ”), which were funded on the Closing Date.”

LIGHTPATH TECHNOLOGIES INC entered into Asset Purchase Agreement with Amorphous Materials, Inc. valued at will not exceed $10.0 million (effective 2026-01-20).

“On January 20, 2026, LightPath Technologies, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), by and among the Company, Amorphous Materials, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (“Buyer”), Amorphous Materials, Inc., a Texas corporation (“Seller”) and other parties thereto”

JABIL INC entered into Officers’ Certificate with U.S. Bank Trust Company, National Association valued at $500 million aggregate principal amount of its 4.200% Senior Notes due 2029 and $500 million aggrega (effective 2026-01-23).

“On January 23, 2026, Jabil Inc. (the “Company”) issued $500 million aggregate principal amount of its 4.200% Senior Notes due 2029 (the “2029 Notes”) and $500 million aggregate principal amount of its 4.750% Senior Notes due 2033 (the “2033 Notes” and together with the 2029 Notes, the “Notes”) in an underwritten public offering (the “Offering”).”

GUESS INC terminated Warrant Transactions with certain Option Counterparties valued at approximately $16,000,000.

“the Company and certain of the Option Counterparties agreed to terminate their related outstanding Hedge Transactions and Warrant Transactions. As a result, such Option Counterparties are required to make an aggregate payment of approximately $33,000,000 to the Company, and the Company is required to make an aggregate payment of approximately $16,000,000 to such Option Counterparties”

GUESS INC terminated Hedge Transactions with certain Option Counterparties valued at approximately $33,000,000.

“the Company and certain of the Option Counterparties agreed to terminate their related outstanding Hedge Transactions and Warrant Transactions. As a result, such Option Counterparties are required to make an aggregate payment of approximately $33,000,000 to the Company, and the Company is required to make an aggregate payment of approximately $16,000,000 to such Option Counterparties”

GUESS INC entered into First Supplemental Indenture with U.S. Bank Trust Company, National Association, as trustee.

“the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”), entered into the First Supplemental Indenture, dated as of the Closing Date (the “ First Supplemental Indenture ”), to the Indenture, dated as of April 17, 2023, between the Company and the Trustee (the “ Original Indenture ” and, together with the First Supplemental Indenture, the “ Indenture ”), relating to the Company’s 3.75% Convertible Senior Notes due 2028 (the “ Notes ”).”

ORAGENICS INC amended Sales Agreement with Dawson James Securities Inc. (effective 2026-01-22).

“On January 22, 2026, the Company and Sales Agent entered into an amendment to the Sales Agreement (the “ Amendment ”), to extend the term of the Sales Agreement to expire at the earlier of (i) the issuance and sale of all of the Shares to or through the Sales Agent and (ii) the later of (X) the expiration of the Company’s Shelf Registration Statement on Form S-3 to be filed pursuant to Rule 415(a)(5) under the Securities Act and (Y) the expiration of any replacement registration statement filed with the Securities and Exchange Commission pursuant to Rule 415(a)(6) under the Securities Act.”

Neuronetics, Inc. amended Amendment No. 4 to Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP (effective 2026-01-15).

“(the “Company”) entered into a Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP, (“Perceptive”) as collateral agent and other lenders defined in the agreement (the “Perceptive Facility”).”

SurgePays, Inc. entered into Underwriting Agreement with R.F. Lafferty & Co., Inc. valued at aggregate gross proceeds of approximately $2.5 million (effective 2026-01-20).

“On January 20, 2026, SurgePays, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with R.F. Lafferty & Co., Inc., the sole book-running manager and underwriter (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 2,000,000 shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a price to the public of $1.25 per share (the “Share Purchase Price”), for aggregate gross proceeds of approximately $2.5 million, before deducting underwriting discounts and commissions and the other estimated Offering expenses.”

Western Midstream Operating, LP entered into Unit Redemption Agreement with Occidental Petroleum Corporation valued at approximately 15.3 million WES common units (effective 2026-01-16).

“the Partnership’s parent, Western Midstream Partners, LP (“WES”) and subsidiaries of Occidental also entered into a unit redemption agreement (“Unit Redemption Agreement”) providing for the transfer to, and redemption by WES, on February 3, 2026 of approximately 15.3 million WES common units.”

Western Midstream Operating, LP entered into GGA Amendment with Anadarko E&P Onshore LLC (effective 2026-01-16).

“On January 16, 2026, Delaware Basin Midstream LLC (“DBM”), a subsidiary of Western Midstream Operating, LP (the “Partnership”), entered into an amendment (“GGA Amendment”) to its Delaware Basin gas gathering agreement with Anadarko E&P Onshore LLC (“AEP”), a subsidiary of Occidental Petroleum Corporation (“Occidental”), dated effective January 1, 2018”

Western Midstream Partners, LP entered into Unit Redemption Agreement with subsidiaries of Occidental Petroleum Corporation (effective 2026-01-16).

“On January 16, 2026, and in connection with the GGA Amendment and related transactions—including an agreement between DBM and a subsidiary of ConocoPhillips pursuant to which DBM will gather and process certain volumes of natural gas already existing on DBM’s system, and conforming modifications to the terms of the associated processing arrangements between subsidiaries of WES and Occidental—WES and subsidiaries of Occidental also entered into a unit redemption agreement (“Unit Redemption Agreement”) providing for the transfer to, and redemption by WES, on February 3, 2026 of approximately 15.3 million WES common units.”

Western Midstream Partners, LP amended GGA Amendment with Anadarko E&P Onshore LLC (a subsidiary of Occidental Petroleum Corporation) (effective 2026-01-16).

“On January 16, 2026, Delaware Basin Midstream LLC (“DBM”), a subsidiary of Western Midstream Partners, LP (“WES”), entered into an amendment (“GGA Amendment”) to its Delaware Basin gas gathering agreement with Anadarko E&P Onshore LLC (“AEP”), a subsidiary of Occidental Petroleum Corporation (“Occidental”), dated effective January 1, 2018”

SunCoke Energy, Inc. entered into metallurgical coke supply agreement with United States Steel Corporation valued at approximately 590,000 tons (effective 2026-01-22).

“On January 22, 2026, Su nCoke Energy, Inc. (the "Company") announced that the Company and United States Steel Corporation (“ U.S. Steel ”) have agreed: (i) to extend the term of their existing metallurgical coke supply agreement for a period of twelve (12) months, from January 1, 2026 to December 31, 2026 (the " 2026 Contract Period "); (ii) that the Company will produce and deliver approximately 590,000 tons of metallurgical coke to U. S. Steel from the Company’s Granite City, Illinois, cokemaking facility during the 2026 Contract Period; and (iii) to maintain the Company’s current minimum steam supply obligation.”

EKSO BIONICS HOLDINGS, INC. entered into Purchase Agreements with certain institutional and accredited investors valued at approximately $5.3 million (effective 2026-01-20).

“On January 20, 2026, Ekso Bionics Holdings, Inc. (the “Company”) entered into securities purchase agreements (collectively, the “Purchase Agreements”) with certain institutional and accredited investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Private Placement”), (i) an aggregate of 5,852 shares of the Company’s newly designated Series B Convertible Preferred Stock, with a par value $0.001 per share and stated value (the “Stated Value”) of $1,000 per share (the “Series B Preferred Stock”) convertible into an aggregate of 711,922 shares (the “Conversion Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”) at a conversion price of $8.22 per share, subject to certain customary adjustments, and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 355,960 shares of Common Stock at an exercise price of $8.22 per share of Common Stock.”

Installed Building Products, Inc. entered into ABL Amendment with Bank of America, N.A. valued at Amendment No. 4 to Credit Agreement, increased commitment to $375.0 million, maturity extended to Ja (effective 2026-01-21).

“On January 21, 2026, the Company entered into Amendment No. 4 to Credit Agreement (the “ABL Amendment”) among the Company, the guarantors party thereto, the lenders party thereto and Bank of America, N.A., as issuing bank, swing bank, administrative agent, joint-lead arranger and joint-lead bookrunner, with JPMorgan Chase Bank, N.A., RBC Capital Markets and KeyBank National Association, each as a joint-lead arranger and a joint book runner and U.S. Bank National Association, as the syndication agent, which amends the Credit Agreement dated as of September 26, 2019 (as amended, the “A&E ABL Credit Agreement”) among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent.”

Installed Building Products, Inc. entered into 2026 Indenture with U.S. Bank Trust Company National Association valued at $500,000,000 aggregate principal amount of 5.625% Senior Notes due 2034 (effective 2026-01-21).

“On January 21, 2026, Installed Building Products, Inc. (the “Company”) completed an offering of $500,000,000 aggregate principal amount of its 5.625% Senior Notes due 2034 (the “2034 Notes”) issued under an Indenture, dated as of January 21, 2026, among the Company, the guarantors named therein and U.S. Bank Trust Company National Association, as trustee (the “2026 Indenture”).”

Urban Edge Properties entered into Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as administrative agent (effective 2026-01-22).

“On January 22, 2026 (the “Effective Date”), the Operating Partnership entered into the Second Amended and Restated Credit Agreement (the “Restated Credit Agreement”), by and among the Operating Partnership, as borrower, Wells Fargo Bank, National Association, as administrative agent”

Avalon GloboCare Corp. terminated Merger Agreement with YOOV Group Holding Limited (effective 2026-01-21).

“The Termination Agreement terminates in its entirety, effective as of January 21, 2026, the Agreement and Plan of Merger dated March 7, 2025, by and among Avalon, Merger Sub and YOOV (the “Merger Agreement”).”

AMERICAN REBEL HOLDINGS INC amended Amendment with Silverback Capital Corporation (effective 2026-01-20).

“On January 20, 2026, the Company entered into a second Amendment to Settlement Agreement and Stipulation (the “Amendment”) with Silverback Capital Corporation (“SCC”), which amended that certain Settlement Agreement and Stipulation dated as of October 28, 2025 (the “Settlement Agreement”).”

AMERICAN REBEL HOLDINGS INC entered into Exchange with Streeterville Capital, LLC valued at $115,000 (effective 2026-01-16).

“On January 16, 2026, the Company entered into a third Exchange Agreement (the “Exchange”) with Streeterville Capital, LLC (“Streeterville”).”

AMERICAN REBEL HOLDINGS INC entered into Securities Purchase Agreement with 1800 Diagonal Lending, LLC valued at $181,700 (effective 2026-01-15).

“On January 15, 2026, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending, LLC, an accredited investor (the “Lender”), pursuant to which the Lender made a loan to the Company, evidenced by a promissory note in the principal amount of $181,700 (the “Note”).”

Shattuck Labs, Inc. entered into Sales Agreement with Leerink Partners LLC valued at $75,000,000 (effective 2026-01-22).

“On January 22, 2026, Shattuck Labs, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (the “Agent”), pursuant to which the Company may offer and sell from time to time shares of the Company’s common stock, $0.0001 par value per share (the “Shares”), through the Agent. The offering and sale of up to $75,000,000 of the Shares has been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-292697) (the “Registration Statement”), which was originally filed with the Securities and Exchange Commission (“SEC”) on January 13, 2026 and declared effective by the SEC on January 21, 2026, the base prospectus contained within the Registration Statement, and a prospectus supplement that was filed with the SEC on January 22, 2026.”

Sachem Capital Corp. amended Amendment No. 2 with Needham Bank (effective 2026-01-21).

“On January 21, 2026, Sachem Capital Corp. (the “Company”) entered into Amendment No. 2 (“Amendment No. 2”) to the Credit, Security and Guaranty Agreement, among the Company, as the guarantor, SN Holdings, LLC, a Connecticut limited liability company and wholly owned subsidiary of the Company, as the borrower, Needham Bank, a Massachusetts co-operative bank, as the administrative agent for the lenders party thereto with respect to the $50 million revolving credit facility (the “Needham Credit Facility”).”

Crypto Co entered into Subscription Agreement with White Dwarf LLC, Ryan Crownholm, and Scott Averitt valued at 90,000,000 shares of common stock for $100,000 (effective 2026-01-15).

“Beginning on January 15, 2026, The Crypto Company (the “ Company ”) executed Subscription Agreements (each, a “ Subscription Agreement ” and collectively, the “ Subscription Agreements ”) with certain institutional and other accredited investors: White Dwarf LLC, Ryan Crownholm, and Scott Averitt (each, an “ Investor ” and collectively, the “ Investors ”), pursuant to which the Company agreed to sell and issue to the Investors an aggregate of 90,000,000 shares of the Company’s common stock, par value $0.001 (“ Common Stock ”) for an aggregate purchase price of $100,000.”

BioAge Labs, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Piper Sandler & Co. and Citigroup Global Markets Inc. as representatives of the underwriters valued at $107.6 million (effective 2026-01-21).

“On January 21, 2026, BioAge Labs, Inc., a Delaware corporation (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Piper Sandler & Co. and Citigroup Global Markets Inc. as representatives of the underwriters named therein (the “ Underwriters ”), pursuant to which the Company agreed to issue and sell 5,897,435 shares (the “ Underwritten Shares ”) of its common stock, par value $0.00001 per share (“ Common Stock ”) to the Underwriters in a public offering at a price of $19.50 per Underwritten Share (the “ Offering ”).”

TALOS ENERGY INC. amended Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $700.0 million (effective 2026-01-20).

“On January 20, 2026, Talos Energy Inc. (the “Company”), Talos Production Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Talos Production”), and certain other direct and indirect subsidiaries of the Company and Talos Production entered into the Amended and Restated Credit Agreement (the “A&R Credit Agreement”) among the Company, Talos Production, as Borrower, JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), the issuing banks, the lenders party thereto, and the other persons from time to time party thereto.”

ALTA EQUIPMENT GROUP INC. entered into Cooperation Agreement with Mill Road Capital III, L.P. (effective 2026-01-21).

“On January 21, 2026, Alta Equipment Group Inc. (the “Company”), entered into a Cooperation Agreement (the “Cooperation Agreement”), between the Company and Mill Road Capital III, L.P. (“Mill Road”), pursuant to which the Company granted Mill Road the right to appoint one observer to attend meetings of the Board, including any meetings of the committees of the Board, and to participate in discussions of matters brought to the Board or any committee thereof.”

MSP Recovery, Inc. entered into Hazel Letter Agreement with Hazel Partners Holdings LLC valued at $300,000 (effective 2026-01-19).

“On January 19, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “Hazel Letter Agreement”) to provide $300,000 to be used solely for operating expenses.”

Janux Therapeutics, Inc. entered into Collaboration Agreement with Bristol-Myers Squibb Company valued at upfront payment of $15 million (effective 2026-01-21).

“On January 21, 2026, Janux Therapeutics, Inc. (“Janux” or the “Company”) and Bristol-Myers Squibb Company (“BMS”) entered into an exclusive license and collaboration agreement (the “Collaboration Agreement”) to develop and commercialize an undisclosed, novel tumor-activated therapeutic targeting a validated solid tumor antigen expressed across several human cancer types (the “Collaboration Target”).”

Global Business Travel Group, Inc. amended Amendment with Morgan Stanley Senior Funding, Inc., as the administrative agent and as the collateral agent valued at increases the aggregate principal amount of such term loans by $100,000,000 (effective 2026-01-21).

“Global Business Travel Group, Inc. (the “Company”), GBT US III LLC (the “Initial Borrower”) and certain subsidiaries of the Company entered into a second amendment (the “Amendment”) to that certain amended and restated credit agreement, dated as of July 26, 2024”

Terns Pharmaceuticals, Inc. amended Amendment to Exclusive Option and License Agreement with Hansoh (Shanghai) Healthtech Co., Ltd. and certain of its affiliates valued at $1.0 million upfront license fee (effective 2026-01-16).

“On January 16, 2026, Terns Pharmaceuticals, Inc. (the “Company”) and its subsidiaries entered into an Amendment (the “Amendment”) to its existing Exclusive Option and License Agreement with Hansoh (Shanghai) Healthtech Co., Ltd. and certain of its affiliates (collectively, “Hansoh”), dated July 27, 2020 (the “Option and License Agreement”).”

Canton Strategic Holdings, Inc. entered into Underwriting Agreement with Clear Street LLC valued at Gross proceeds approximately $55 million; offering of 1,800,000 shares of common stock at $2.9200 pe (effective 2026-01-20).

“On January 20, 2026, Tharimmune, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Clear Street LLC, as the sole underwriter (the “Underwriter”), relating to an underwritten registered offering to a single institutional investor (the “Offering”) of (i) 1,800,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at an offering price of $2.9200 (the “Offering Price”), and (ii) certain pre-funded warrants (the “Pre-Funded Warrants”), at an offering price of Offering Price less $0.0001 per Pre-Funded Warrant, to purchase up to 17,000,000 shares of Common Stock.”

CDT Equity Inc. entered into Purchase Agreement with an institutional investor valued at up to $25 million (effective 2026-01-16).

“On January 16, 2026, CDT Equity Inc. (the “Company”), entered into a directed stock purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Purchaser”) relating to an equity line of credit facility (the “ELOC”).”

Israel Acquisitions Corp amended Trust Agreement Amendment with Equiniti Trust Company, LLC valued at Amendment to extend the business combination deadline from January 18, 2026 to January 18, 2027, all (effective 2026-01-16).

“As approved by the shareholders of Israel Acquisitions Corp (the “ Company ”), by special resolution, at an extraordinary general meeting of shareholders held on January 16, 2026 (the “ Meeting ”), on January 16, 2026, the Company entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment Management Trust Agreement, dated as of January 12, 2023 and amended on January 8, 2024 by Amendment No. 1 and on January 6, 2025 by Amendment No. 2, with Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Trust Company) (the “ Trustee ”).”

Strive, Inc. entered into Underwriting Agreement with Barclays Capital Inc. and Cantor Fitzgerald & Co., as the joint book-running managers and representatives of the several underwriters valued at approximately $118.8 million (effective 2026-01-22).

“On January 22, 2026, Strive, Inc. (“Strive” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc. and Cantor Fitzgerald & Co., as the joint book-running managers and representatives of the several underwriters (the “Underwriters”), relating to the issuance and sale in an underwritten offering (the “Offering”) registered under the Securities Act of 1933, as amended (the “Securities Act”), of 1,320,000 shares (the “Shares”) of the Company’s Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share (the “SATA Stock”), an upsize over the $150 million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges , at a public offering price of $90 per share.”

Sealy Industrial Partners IV, LP amended First Amended and Restated Credit Agreement with KeyBank National Association valued at $150 million (effective 2026-01-15).

“On January 15, 2026, Sealy Industrial Partners IV OP, LP (the “Borrower”), a Georgia limited partnership and indirect subsidiary of Sealy Industrial Partners IV, LP (the “Registrant”), entered into that certain First Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with KeyBank National Association (“KeyBank")”

Phillip Street BDC LLC entered into Fifth Amendment to Secured Credit Facility with Ally Bank, as administrative agent, arranger and swingline lender, and State Street Bank and Trust Company, as collateral custodian, and the lenders party thereto valued at $750,000,000 (effective 2026-01-16).

“On January 16, 2026, Phillip Street Middle Market Lending Investments LLC ("SPV"), an indirectly wholly owned subsidiary of Phillip Street Middle Market Lending Fund LLC (the "Company") entered into a fifth amendment (the "Amendment") to its secured credit facility, dated as of February 10, 2023 (as amended, supplemented or otherwise modified and in effect from time to time, including by the Amendment, the "Ally Credit Facility") by and among the Company, as collateral manager and transferor, Phillip Street Middle Market Lending Investment Holdings LLC, as equityholder, the SPV, as borrower, each of the lenders from time to time party thereto (the "Lenders"), Ally Bank, as administrative agent, arranger and swingline lender, and State Street Bank and Trust Company, as collateral custodian.”

Worthington Steel, Inc. entered into BCA with Klöckner & Co SE valued at €11.00 for each Kloeckner Share (effective 2026-01-15).

“On January 15, 2026, Worthington Steel, Inc., an Ohio corporation (the “ Company ” or “ Worthington Steel ”), and Worthington Steel GmbH, a limited liability company established under German law ( Gesellschaft mit beschränkter Haftung ) (“ Bidder ”), and Klöckner & Co SE, a European stock corporation ( societas europaea ) organized under the laws of Germany (“ Kloeckner ”), entered into a business combination agreement (the “ BCA ”).”

Bayview Acquisition Corp amended Amendment No. 3 to the Merger Agreement with the parties to the Merger Agreement (effective 2026-01-21).

“On January 21, 2026, the parties to the Merger Agreement entered into Amendment No. 3 to the Merger Agreement (the “Third Amendment”), pursuant to which the Outside Closing Date (as defined in the Merger Agreement) was extended to June 15, 2026.”